Stay updated on SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.

Latest updates to the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference0.3%
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check84 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference0.1%
Stay in the know with updates to SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.